Artikel ; Online: Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with
Omics : a journal of integrative biology
2024 Band 28, Heft 2, Seite(n) 59–75
Abstract: High-grade gliomas (HGGs) are extremely aggressive primary brain tumors with high mortality rates. Despite notable progress achieved by clinical research and biomarkers emerging from proteomics studies, efficacious drugs and therapeutic targets are ... ...
Abstract | High-grade gliomas (HGGs) are extremely aggressive primary brain tumors with high mortality rates. Despite notable progress achieved by clinical research and biomarkers emerging from proteomics studies, efficacious drugs and therapeutic targets are limited. This study used targeted proteomics, |
---|---|
Mesh-Begriff(e) | Humans ; Temozolomide/pharmacology ; Molecular Docking Simulation ; Drug Repositioning/methods ; Glioma/drug therapy ; Indazoles ; Pyrimidines ; Sulfonamides |
Chemische Substanzen | pazopanib (7RN5DR86CK) ; Temozolomide (YF1K15M17Y) ; Indazoles ; Pyrimidines ; Sulfonamides |
Sprache | Englisch |
Erscheinungsdatum | 2024-02-06 |
Erscheinungsland | United States |
Dokumenttyp | Journal Article |
ZDB-ID | 2030312-9 |
ISSN | 1557-8100 ; 1536-2310 |
ISSN (online) | 1557-8100 |
ISSN | 1536-2310 |
DOI | 10.1089/omi.2023.0256 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.